Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3).
Wiedmer T, Zhao J, Li L, Zhou Q, Hevener A, Olefsky JM, Curtiss LK, Sims PJ. Proc Natl Acad Sci U S A. 2004 Sep 7; 101(36):13296-301. Epub 2004 Aug 24.